SG11201702202UA - Aqueous composition - Google Patents
Aqueous compositionInfo
- Publication number
- SG11201702202UA SG11201702202UA SG11201702202UA SG11201702202UA SG11201702202UA SG 11201702202U A SG11201702202U A SG 11201702202UA SG 11201702202U A SG11201702202U A SG 11201702202UA SG 11201702202U A SG11201702202U A SG 11201702202UA SG 11201702202U A SG11201702202U A SG 11201702202UA
- Authority
- SG
- Singapore
- Prior art keywords
- aqueous composition
- aqueous
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014194679 | 2014-09-25 | ||
| PCT/JP2015/077013 WO2016047719A1 (ja) | 2014-09-25 | 2015-09-25 | 水性組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201702202UA true SG11201702202UA (en) | 2017-04-27 |
Family
ID=55581238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201702202UA SG11201702202UA (en) | 2014-09-25 | 2015-09-25 | Aqueous composition |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10376523B2 (pl) |
| EP (1) | EP3199160B1 (pl) |
| JP (6) | JP6236166B2 (pl) |
| KR (1) | KR101830588B1 (pl) |
| CN (1) | CN106714806B (pl) |
| BR (1) | BR112017006150A2 (pl) |
| CA (1) | CA2962562A1 (pl) |
| DK (1) | DK3199160T3 (pl) |
| ES (1) | ES2779314T3 (pl) |
| HU (1) | HUE048790T2 (pl) |
| MX (1) | MX2017003941A (pl) |
| MY (1) | MY177032A (pl) |
| PL (1) | PL3199160T3 (pl) |
| PT (1) | PT3199160T (pl) |
| SG (1) | SG11201702202UA (pl) |
| TW (1) | TWI668215B (pl) |
| WO (1) | WO2016047719A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016047721A1 (ja) * | 2014-09-25 | 2016-03-31 | 興和株式会社 | 医薬製剤 |
| CN113262226B (zh) * | 2021-04-19 | 2023-05-16 | 杭州市第一人民医院 | 利舒地尔在制备细菌感染治疗药物中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4212149B2 (ja) | 1998-06-11 | 2009-01-21 | 株式会社デ・ウエスタン・セラピテクス研究所 | 医薬 |
| JPWO2005108446A1 (ja) | 2004-05-07 | 2008-03-21 | 旭硝子株式会社 | 含フッ素共重合体とその製造方法およびそれを含むレジスト組成物 |
| US20060142270A1 (en) | 2004-12-23 | 2006-06-29 | Kowa Co., Ltd. | Preventing or treating agent for glaucoma |
| TWI367098B (en) * | 2004-12-23 | 2012-07-01 | Kowa Co | Treating agent for glaucoma |
| WO2006115244A1 (ja) | 2005-04-25 | 2006-11-02 | D. Western Therapeutics Institute, Inc. | ４－ブロモイソキノリン誘導体及びこれを含有する医薬 |
| JP2006348028A (ja) * | 2005-05-19 | 2006-12-28 | Kowa Co | 緑内障予防又は治療剤 |
| KR101326425B1 (ko) * | 2005-06-21 | 2013-11-11 | 코와 가부시키가이샤 | 녹내장의 예방 또는 치료제 |
| US8193193B2 (en) * | 2005-07-12 | 2012-06-05 | Kowa Co., Ltd. | Agent for prevention or treatment of glaucoma |
| US7867999B1 (en) * | 2005-12-22 | 2011-01-11 | Alcon Research, Ltd. | Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-mediated diseases and conditions |
| US20080064681A1 (en) * | 2006-09-11 | 2008-03-13 | Hiroyoshi Hidaka | Therapeutic agent for treating glaucoma |
| CA3099517C (en) | 2012-07-13 | 2022-04-26 | Santen Pharmaceutical Co., Ltd. | Combinations comprising a sulfonamide compound for the treatment of glaucoma or ocular hypertension |
| US20160339018A1 (en) | 2013-04-24 | 2016-11-24 | Kyushu University, National University Corporation | Therapeutic agent for ocular fundus disease |
-
2015
- 2015-09-25 JP JP2016550376A patent/JP6236166B2/ja active Active
- 2015-09-25 EP EP15844047.9A patent/EP3199160B1/en active Active
- 2015-09-25 DK DK15844047.9T patent/DK3199160T3/da active
- 2015-09-25 PL PL15844047T patent/PL3199160T3/pl unknown
- 2015-09-25 CA CA2962562A patent/CA2962562A1/en not_active Abandoned
- 2015-09-25 MX MX2017003941A patent/MX2017003941A/es unknown
- 2015-09-25 ES ES15844047T patent/ES2779314T3/es active Active
- 2015-09-25 PT PT158440479T patent/PT3199160T/pt unknown
- 2015-09-25 MY MYPI2017700943A patent/MY177032A/en unknown
- 2015-09-25 WO PCT/JP2015/077013 patent/WO2016047719A1/ja active Application Filing
- 2015-09-25 HU HUE15844047A patent/HUE048790T2/hu unknown
- 2015-09-25 KR KR1020177006791A patent/KR101830588B1/ko active Protection Beyond IP Right Term
- 2015-09-25 CN CN201580051331.0A patent/CN106714806B/zh active Active
- 2015-09-25 BR BR112017006150A patent/BR112017006150A2/pt not_active Application Discontinuation
- 2015-09-25 US US15/514,259 patent/US10376523B2/en not_active Expired - Fee Related
- 2015-09-25 SG SG11201702202UA patent/SG11201702202UA/en unknown
- 2015-09-25 TW TW104131861A patent/TWI668215B/zh active
-
2017
- 2017-10-26 JP JP2017207302A patent/JP2018012736A/ja not_active Ceased
-
2019
- 2019-08-21 JP JP2019150783A patent/JP2019194273A/ja active Pending
-
2021
- 2021-05-06 JP JP2021078649A patent/JP2021143179A/ja active Pending
-
2023
- 2023-01-31 JP JP2023012895A patent/JP2023052791A/ja active Pending
-
2024
- 2024-06-24 JP JP2024101523A patent/JP2024111298A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP6236166B2 (ja) | 2017-11-22 |
| ES2779314T3 (es) | 2020-08-14 |
| JP2021143179A (ja) | 2021-09-24 |
| PT3199160T (pt) | 2020-04-08 |
| JP2024111298A (ja) | 2024-08-16 |
| BR112017006150A2 (pt) | 2017-12-12 |
| CN106714806A (zh) | 2017-05-24 |
| EP3199160B1 (en) | 2020-03-11 |
| JP2023052791A (ja) | 2023-04-12 |
| CA2962562A1 (en) | 2016-03-31 |
| EP3199160A1 (en) | 2017-08-02 |
| TWI668215B (zh) | 2019-08-11 |
| MY177032A (en) | 2020-09-02 |
| DK3199160T3 (da) | 2020-04-20 |
| JP2018012736A (ja) | 2018-01-25 |
| JPWO2016047719A1 (ja) | 2017-06-29 |
| TW201619147A (zh) | 2016-06-01 |
| JP2019194273A (ja) | 2019-11-07 |
| WO2016047719A1 (ja) | 2016-03-31 |
| EP3199160A4 (en) | 2018-04-25 |
| CN106714806B (zh) | 2020-03-03 |
| KR101830588B1 (ko) | 2018-02-20 |
| US10376523B2 (en) | 2019-08-13 |
| HUE048790T2 (hu) | 2020-09-28 |
| KR20170063565A (ko) | 2017-06-08 |
| US20170290841A1 (en) | 2017-10-12 |
| MX2017003941A (es) | 2017-06-26 |
| PL3199160T3 (pl) | 2020-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201704737SA (en) | Novel aqueous composition | |
| HK1218859A1 (zh) | 組合物 | |
| HK1214967A1 (zh) | 組合物 | |
| SG11201704735WA (en) | Composition | |
| SG11201704740WA (en) | Aqueous composition | |
| GB201403017D0 (en) | Composition | |
| PL3216451T3 (pl) | Wodna kompozycja okulistyczna | |
| ZA201704464B (en) | Composition | |
| HK1244432A1 (zh) | 組合物 | |
| GB201414910D0 (en) | Composition | |
| GB201403561D0 (en) | Composition | |
| GB201414555D0 (en) | Composition | |
| GB201410493D0 (en) | Composition | |
| HK1226296A1 (zh) | 用於產生視黃酸的試劑 | |
| SG11201702202UA (en) | Aqueous composition | |
| GB201519442D0 (en) | Composition | |
| ZA201606127B (en) | Composition | |
| GB201420628D0 (en) | Composition | |
| GB201415483D0 (en) | Composition | |
| GB201404390D0 (en) | Composition | |
| GB201402648D0 (en) | Composition | |
| IL250781A0 (en) | preparation | |
| GB201503484D0 (en) | Composition | |
| GB201502355D0 (en) | Composition | |
| GB201421660D0 (en) | Composition |